Aug 2026· Bolu Abant Izzet Baysal Universitesi, Tip Fakultesi, Abant Tip Dergisi· 0 citations· 73 references
TL;DR
Future studies should focus on developing explainable and multimodal frameworks, supported by cross-institutional collaborations and prospective validation, to ensure both methodological robustness and clinical credibility.
Abstract
Migraine is a complex neurological disorder characterised by recurrent headaches, sensory disturbances, and autonomic dysfunction. Despite its high prevalence, accurate diagnosis and effective management remain challenging due to the variability of symptoms and the absence of reliable biomarkers. In recent years, approaches based on artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), have offered new perspectives for improving diagnostic accuracy and disease classification. ML models such as support vector machines and random forests have shown potential in identifying neuroimaging and electrophysiological biomarkers, while convolutional neural networks (CNNs) are capable of extracting meaningful patterns from electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) data. Nevertheless, most studies are limited by small, homogeneous datasets and the lack of external validation, which restricts reproducibility and generalisability. Beyond technical performance, the transition of AI tools from research to clinical settings remains constrained by regulatory issues, limited interpretability, and difficulties in integration with existing healthcare systems. Future studies should focus on developing explainable and multimodal frameworks, supported by cross-institutional collaborations and prospective validation, to ensure both methodological robustness and clinical credibility. In the long term, the integration of such approaches may support earlier and more precise identification of migraine subtypes, guide individualised treatment strategies, and contribute to better patient outcomes.
Parkinson’s disease (PD) is an increasingly developing neurological disorder that affects both motor and non-motor functions, resulting in a reduction of quality of life. Early detection of PD is highly challenging, as the occurrence of noticeable symptoms happens only after considerable neurodegeneration. Similarly, c...
Anuradha Komati, B. T. Reddy· 2026 7th International Confe...· 0 citations
Dementia-related disorders, particularly Alzheimer’s disease (AD), represent a growing global health challenge, increasing the need for early and reliable detection. Electroencephalography (EEG), a non-invasive and cost-effective neurophysiological modality, has emerged as a promising tool for identifying neural signat...
Oluwatoyin Kode, Mitch Hong, Long Nguyen et al.· ET Journal· 0 citations
This systematic review consolidates recent advances in ML for MS diagnosis and monitoring and proposes a task-based taxonomy linking clinical objectives to methodological families, providing a comprehensive roadmap toward building robust, data-efficient, and trustworthy ML systems for clinical decision support in MS.
Marthe Elgawly, Beyza Nur Elaslan, Marco Cascio et al.· IEEE Access· 0 citations
Epilepsy and migraine are prone to clinical misdiagnosis due to overlapping clinical manifestations, while the limited availability of electroencephalogram (EEG) data further complicates accurate differential diagnosis. To address this challenge, this study proposes a three-class classification framework for epilepsy,...
Shiqi Li, Yao Miao· 2026 IEEE International Conf...· 0 citations
Artificial intelligence is being considered as a means of assisting psychiatric diagnosis, risk prediction, and long-term monitoring. Such applications in psychiatry have clinical relevance due to the fact that most psychiatric diagnosis is still based on interview, observation, and self-report, and also because it rel...
R. Wojtan, A. Szeszko, W. Czernek et al.· International Journal of Inn...· 0 citations
The need to develop large, well‐balanced datasets, the application of explainable AI techniques, standardization and regulatory guidelines for facilitating the clinical translation of ASD detection systems are suggested.
Anupama N, Chandrashekar M. Patil· International Journal of Dev...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.